A study published in Engineering has identified fucosylated immunoglobulin G (IgG) as a key mediator contributing to adipose ...

Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved ...

A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, ...

A newly identified receptor could redefine how scientists treat bone loss by directly restoring the balance between bone ...

A study published in Engineering has identified fucosylated immunoglobulin G (IgG) as a key mediator contributing to adipose tissue dysfunction during ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the independent Data ...

The global lentiviral vector CDMO market is projected to grow at a CAGR of 8% over the next five years. This growth is driven by rising demand for gene and cell therapies, an expanding pipeline of ...

The receptor, called GPR133, appears to help bones stay strong by supporting the cells that build bone and restraining the ...

Korea showcases cancer advances at AACR with targeted and RNA therapies, CDMO push Korean biotechs spotlight early wins in ...

Being an early bird or a night owl may be defined by your genetics, but research suggests that those who rise early may ...

Using single-nucleus RNA sequencing, the authors map transcriptional changes in the rat ventral tegmental area following chronic inflammatory pain and acute morphine exposure. Notably, their ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...